CD16−CD56bright cells release proinflammatory cytokines such as IFN-γ which drives inflammatory mechanisms that regulate tumor initiation, immunoevasion, survival, and outgrowth [20], [21]. The gene discussed is IFNG; the disease is neoplasm.